1. Skip to header
  2. Skip to main
  3. Skip to content
  4. Skip to sidebar
  5. Skip to footer
  • Home > Blog > Mesothelioma > Time Running out to Apply for Fellowship Award for the Research of Mesothelioma or Other Lung Cancers
Posted on Monday, Dec 28, 2009

Time Running out to Apply for Fellowship Award for the Research of Mesothelioma or Other Lung Cancers

With a goal to “reward scientific excellence and to encourage innovative investigations in the field of lung cancer prevention research” the International Association for the Study of Lung Cancer (IASLC) is accepting applications for Fellowships and Young Investigator awards until January 10, 2010.

The awards are supported through educational grants from GlaxoSmithKline, Sanofi-Aventis, AstraZeneca, Celgene, Pfizer, Eli Lilly, and OSI. Eli Lilly is the maker of Alimta which is used in the treatment of malignant mesothelioma.

Mesothelioma, a cancer caused by asbestos exposure, can affect the lining of the lungs known as pleural mesothelioma, or the lining of the abdomen resulting in peritoneal mesothelioma. In rare instances, the lining of the heart can be affected resulting in pericardial mesothelioma.

A decision on applications will be reached by March 2010.